- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1373
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1373 companies
Xiamen Kingdomway Group
Market Cap: CN¥11.5b
Engages in the manufacturing and sale of the nutrition and health products in China and internationally.
002626
CN¥18.61
7D
-2.4%
1Y
28.2%
Changzhou Qianhong BiopharmaLTD
Market Cap: CN¥11.5b
Manufactures and distributes polysaccharide and protease drugs in China.
002550
CN¥8.99
7D
-5.8%
1Y
62.9%
Viridian Therapeutics
Market Cap: US$1.6b
Engages in discovering, developing, and commercializing treatments for serious and rare diseases.
VRDN
US$19.08
7D
-2.8%
1Y
-17.3%
Square Pharmaceuticals
Market Cap: ৳193.4b
Manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳218.40
7D
-0.7%
1Y
-4.9%
Mayinglong Pharmaceutical Group
Market Cap: CN¥11.3b
Engages in the manufacturing and sale of Chinese and Western medicines primarily in China.
600993
CN¥26.43
7D
-1.2%
1Y
5.6%
Liaoning Chengda BiotechnologyLtd
Market Cap: CN¥11.1b
A biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China.
688739
CN¥27.05
7D
0.07%
1Y
6.4%
Sawai Group Holdings
Market Cap: JP¥232.7b
Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.
4887
JP¥2,059.00
7D
1.4%
1Y
-0.9%
Phibro Animal Health
Market Cap: US$1.6b
Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.
PAHC
US$38.04
7D
-6.2%
1Y
72.1%
Indegene
Market Cap: ₹137.3b
Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
INDGN
₹571.90
7D
-2.4%
1Y
-13.8%
Tianjin Chase Sun PharmaceuticalLtd
Market Cap: CN¥11.0b
Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.
300026
CN¥3.66
7D
-2.4%
1Y
1.7%
China Traditional Chinese Medicine Holdings
Market Cap: HK$12.0b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.38
7D
8.2%
1Y
-44.8%
Harmony Biosciences Holdings
Market Cap: US$1.5b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$27.04
7D
-17.1%
1Y
-32.0%
Vericel
Market Cap: US$1.5b
A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.
VCEL
US$29.84
7D
-6.3%
1Y
-32.3%
Faes Farma
Market Cap: €1.3b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.
FAE
€4.20
7D
0.2%
1Y
14.1%
HBM Holdings
Market Cap: HK$11.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$14.01
7D
-8.8%
1Y
961.4%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$11.8b
A biotechnology company, engages in the research and development of novel antibody-based drugs in the People’s Republic of China, the United States, and internationally.
2315
HK$28.60
7D
4.0%
1Y
309.2%
Avadel Pharmaceuticals
Market Cap: US$1.5b
Operates as a biopharmaceutical company in the United States.
AVDL
US$15.33
7D
-5.5%
1Y
21.7%
Shanghai Haohai Biological Technology
Market Cap: HK$11.7b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$26.00
7D
-2.4%
1Y
-22.3%
Zhejiang CONBA PharmaceuticalLtd
Market Cap: CN¥10.7b
Engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China.
600572
CN¥4.35
7D
-2.0%
1Y
-4.8%
SKAN Group
Market Cap: CHF 1.2b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 53.50
7D
-7.8%
1Y
-32.4%
10x Genomics
Market Cap: US$1.5b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
TXG
US$11.95
7D
-9.9%
1Y
-46.4%
Nippon Shinyaku
Market Cap: JP¥223.0b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥3,355.00
7D
0.4%
1Y
-12.1%
KPC PharmaceuticalsInc
Market Cap: CN¥10.6b
A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People’s Republic of China and internationally.
600422
CN¥13.89
7D
-1.6%
1Y
-5.4%
Abbisko Cayman
Market Cap: HK$11.6b
Engages in the research and development of pharmaceutical products in the People’s Republic of China and the European Union.
2256
HK$16.95
7D
-2.9%
1Y
398.5%
Ardelyx
Market Cap: US$1.5b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$5.96
7D
-7.2%
1Y
-6.3%
Structure Therapeutics
Market Cap: US$1.5b
A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.
GPCR
US$24.99
7D
7.6%
1Y
-39.8%
Heilongjiang ZBD Pharmaceutical
Market Cap: CN¥10.5b
Heilongjiang ZBD Pharmaceutical Co., Ltd.
603567
CN¥11.16
7D
-3.9%
1Y
-0.9%
Ascletis Pharma
Market Cap: HK$11.4b
A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.
1672
HK$10.34
7D
-3.2%
1Y
848.6%
AcrobiosystemsLtd
Market Cap: CN¥10.4b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥59.90
7D
1.9%
1Y
125.1%
Granules India
Market Cap: ₹128.7b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.
532482
₹530.30
7D
-2.4%
1Y
-2.5%
Trulieve Cannabis
Market Cap: CA$2.0b
Operates as a cannabis retailer.
TRUL
CA$9.90
7D
-2.6%
1Y
-37.9%
Hualan Biological Vaccine
Market Cap: CN¥10.3b
Engages in the research and development, production, and sale of vaccines and genetic engineering biological products in China.
301207
CN¥17.02
7D
-1.4%
1Y
-5.9%
AbCellera Biologics
Market Cap: US$1.4b
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$4.65
7D
-1.5%
1Y
81.6%
Youcare Pharmaceutical Group
Market Cap: CN¥10.1b
Engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
688658
CN¥22.33
7D
-5.8%
1Y
29.2%
Chengdu Easton Biopharmaceuticals
Market Cap: CN¥10.1b
Engages in the research, development, manufacture, and commercialization of pharmaceutical products.
688513
CN¥54.85
7D
-7.3%
1Y
49.4%
Tilray Brands
Market Cap: US$1.4b
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.
TLRY
US$1.19
7D
-5.6%
1Y
-31.6%